PRPO - Precipio granted 180 day extension by Nasdaq to regain compliance
2023-04-28 03:11:10 ET
- Specialty cancer diagnostics company Precipio ( NASDAQ: PRPO ) has been granted a 180-day extension by Nasdaq to allow the company to meet the required minimum $1.00 per share closing bid price for 10 consecutive business days.
- The stock price is down 1% during late hours on Thursday.
For further details see:
Precipio granted 180 day extension by Nasdaq to regain compliance